← Back to Search

Behavioural Intervention

Mindful Walking for Cognitive Health

N/A
Recruiting
Led By Chih-Hsiang "Jason" Yang, PhD
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American ages 60 and above
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will test if mindful walking helps protect cognitive health in African American seniors at risk of neuropsychological diseases.

Who is the study for?
This trial is for African American individuals aged 60 and above who are medically stable, have mild cognitive decline or MCI, are not very active physically, can see and hear well enough to do study tasks, speak English, can consent to participate, and are willing to be randomly assigned to one of two groups. It's not for those with certain brain conditions like strokes or epilepsy, severe psychiatric disorders, those who can't walk without help, or anyone planning major life changes soon.Check my eligibility
What is being tested?
The study is testing whether a program of mindful walking helps maintain the thinking abilities of older African Americans at risk for brain health issues. Participants will either start the walking program right away or after a delay. The researchers want to see if there's any difference in mental function between these two groups over time.See study design
What are the potential side effects?
Since this intervention involves mindful walking which is a low-impact physical activity combined with mindfulness practice; side effects might include typical exercise-related discomforts such as muscle soreness but significant side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am African American and 60 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12,18,24 weeks follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12,18,24 weeks follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognitive Function as assessed by the Montreal Cognitive Assessment (MoCA)
Everyday Cognition as assessed by the NIH Mobile Toolbox
Secondary outcome measures
Depressive Symptoms as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)
Device-based Physical Activity Levels as assessed by the activPAL Accelerometer
Mindfulness Level as assessed by the Mindfulness Attention Awareness Scale and Five Facet Mindfulness Questionnaire
+6 more
Other outcome measures
Body Mass Index (BMI) as calculated by the height and weight measures
Daily Functioning as assessed by the Brody Instrumental Activities of Daily Living Scale (IADL)
Grip Strength as measured using the digital dynamometer
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mindful walkingExperimental Treatment1 Intervention
Complete a 24-session outdoor mindful walking intervention over 3 months
Group II: Delayed mindful walking groupExperimental Treatment1 Intervention
Option to complete a delayed 24-session mindful walking

Find a Location

Who is running the clinical trial?

University of South CarolinaLead Sponsor
213 Previous Clinical Trials
121,142 Total Patients Enrolled
3 Trials studying Health Behaviors
2,279 Patients Enrolled for Health Behaviors
Centers for Disease Control and PreventionFED
877 Previous Clinical Trials
22,478,090 Total Patients Enrolled
5 Trials studying Health Behaviors
8,391 Patients Enrolled for Health Behaviors
Chih-Hsiang "Jason" Yang, PhDPrincipal InvestigatorUniversity of South Carolina
~0 spots leftby Jun 2024